AssetMark Inc’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-182
| Closed | -$2.92K | – | 1961 |
|
2023
Q3 | $2.92K | Buy |
182
+51
| +39% | +$818 | ﹤0.01% | 1438 |
|
2023
Q2 | $3.04K | Hold |
131
| – | – | ﹤0.01% | 1386 |
|
2023
Q1 | $3.04K | Sell |
131
-86
| -40% | -$2K | ﹤0.01% | 1365 |
|
2022
Q4 | $3.15K | Buy |
217
+1
| +0.5% | +$15 | ﹤0.01% | 1398 |
|
2022
Q3 | $4K | Hold |
216
| – | – | ﹤0.01% | 1331 |
|
2022
Q2 | $4K | Buy |
216
+123
| +132% | +$2.28K | ﹤0.01% | 1322 |
|
2022
Q1 | $2K | Sell |
93
-4
| -4% | -$86 | ﹤0.01% | 1426 |
|
2021
Q4 | $3K | Buy |
97
+7
| +8% | +$216 | ﹤0.01% | 1325 |
|
2021
Q3 | $3K | Hold |
90
| – | – | ﹤0.01% | 1225 |
|
2021
Q2 | $3K | Sell |
90
-5
| -5% | -$167 | ﹤0.01% | 1164 |
|
2021
Q1 | $3K | Sell |
95
-14
| -13% | -$442 | ﹤0.01% | 1115 |
|
2020
Q4 | $2K | Hold |
109
| – | – | ﹤0.01% | 1222 |
|
2020
Q3 | $1K | Hold |
109
| – | – | ﹤0.01% | 1253 |
|
2020
Q2 | $1K | Buy |
109
+38
| +54% | +$349 | ﹤0.01% | 1191 |
|
2020
Q1 | $1K | Buy |
71
+10
| +16% | +$141 | ﹤0.01% | 1274 |
|
2019
Q4 | $2K | Buy |
61
+9
| +17% | +$295 | ﹤0.01% | 1248 |
|
2019
Q3 | $1K | Sell |
52
-52
| -50% | -$1K | ﹤0.01% | 1247 |
|
2019
Q2 | $3K | Buy |
104
+29
| +39% | +$837 | ﹤0.01% | 1122 |
|
2019
Q1 | $2K | Sell |
75
-8
| -10% | -$213 | ﹤0.01% | 1178 |
|
2018
Q4 | $2K | Sell |
83
-49
| -37% | -$1.18K | ﹤0.01% | 1223 |
|
2018
Q3 | $6K | Sell |
132
-16
| -11% | -$727 | ﹤0.01% | 1140 |
|
2018
Q2 | $6K | Sell |
148
-2
| -1% | -$81 | ﹤0.01% | 1140 |
|
2018
Q1 | $4K | Sell |
150
-5
| -3% | -$133 | ﹤0.01% | 1187 |
|
2017
Q4 | $5K | Buy |
+155
| New | +$5K | ﹤0.01% | 1252 |
|